STOCK TITAN

ETRACS Whitney US Critical Techs ETN SEC Filings

WUCT NYSE

Welcome to our dedicated page for ETRACS Whitney US Critical Techs ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ETRACS Whitney US Critical Techs ETN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ETRACS Whitney US Critical Techs ETN's regulatory disclosures and financial reporting.

Rhea-AI Summary

Eos Energy Enterprises, Inc. (EOSE) – Form 144 filing discloses a proposed insider sale of common stock.

  • Seller & broker: 47,254 common shares are to be sold for the account of Nathan Kroeker through UBS Financial Services Inc., Eleven Madison Ave., New York.
  • Transaction size: Aggregate market value is $243,358.10, representing roughly 0.02 % of the 227,589,833 shares outstanding.
  • Planned timing & venue: Sale is targeted for 07 / 08 / 2025 on the Nasdaq.
  • Source of shares: Shares derive from RSU vesting on 07 / 05 / 2025; 47,254 units vested on that date.
  • Recent selling activity: Over the last three months Kroeker sold 152,856 shares on 05 / 16 / 2025 for $1,048,853 and 24,124 shares on 07 / 07 / 2025 for $125,801.84.

The filing is a notice only; execution depends on market conditions, and Rule 144 limits apply. The volume is immaterial versus total shares, but the continued disposition may be monitored by investors assessing insider sentiment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Eos Energy Enterprises, Inc. (EOSE) – Form 144 filing discloses a proposed insider sale of common stock.

  • Seller & broker: 47,254 common shares are to be sold for the account of Nathan Kroeker through UBS Financial Services Inc., Eleven Madison Ave., New York.
  • Transaction size: Aggregate market value is $243,358.10, representing roughly 0.02 % of the 227,589,833 shares outstanding.
  • Planned timing & venue: Sale is targeted for 07 / 08 / 2025 on the Nasdaq.
  • Source of shares: Shares derive from RSU vesting on 07 / 05 / 2025; 47,254 units vested on that date.
  • Recent selling activity: Over the last three months Kroeker sold 152,856 shares on 05 / 16 / 2025 for $1,048,853 and 24,124 shares on 07 / 07 / 2025 for $125,801.84.

The filing is a notice only; execution depends on market conditions, and Rule 144 limits apply. The volume is immaterial versus total shares, but the continued disposition may be monitored by investors assessing insider sentiment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $375,000 of unsubordinated, unsecured Trigger Autocallable Contingent Yield Notes linked to Marvell Technology, Inc. (MRVL) common stock. The notes are issued at $10 each, settle on 10-Jul-2025, and mature on 10-Jan-2028 unless called earlier. Investors receive a contingent monthly coupon of 23.84% p.a. ($0.1987 per note) only when MRVL’s closing price on the relevant observation date is at or above the Coupon Barrier of $52.52 (73 % of the initial level).

  • Automatic call: If MRVL closes at or above the Initial Level of $71.95 on any monthly observation date (other than the final valuation date), UBS redeems the notes at par plus the coupon, ending further payments.
  • Principal at risk: If not called, full principal is repaid only when the Final Level on 6-Jan-2028 is at or above the Downside Threshold of $46.77 (65 % of the initial level). Otherwise, repayment equals $10 × (1 + Underlying Return), exposing investors to the full downside of MRVL below the threshold.
  • Estimated initial value: $9.79, below the $10 issue price, reflecting dealer discount (1.75 %), hedging and issuance costs.
  • Liquidity & credit: Notes are not exchange-listed; secondary market making is discretionary. All payments depend on UBS AG’s credit; FINMA resolution powers could impose write-downs or conversion to equity.
Key dates include 31 monthly observation dates beginning 7-Aug-2025. Minimum purchase is 100 notes ($1,000). The product suits investors seeking high contingent income, willing to accept equity-like downside, illiquidity, and issuer credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering $375,000 of unsubordinated, unsecured Trigger Autocallable Contingent Yield Notes linked to Marvell Technology, Inc. (MRVL) common stock. The notes are issued at $10 each, settle on 10-Jul-2025, and mature on 10-Jan-2028 unless called earlier. Investors receive a contingent monthly coupon of 23.84% p.a. ($0.1987 per note) only when MRVL’s closing price on the relevant observation date is at or above the Coupon Barrier of $52.52 (73 % of the initial level).

  • Automatic call: If MRVL closes at or above the Initial Level of $71.95 on any monthly observation date (other than the final valuation date), UBS redeems the notes at par plus the coupon, ending further payments.
  • Principal at risk: If not called, full principal is repaid only when the Final Level on 6-Jan-2028 is at or above the Downside Threshold of $46.77 (65 % of the initial level). Otherwise, repayment equals $10 × (1 + Underlying Return), exposing investors to the full downside of MRVL below the threshold.
  • Estimated initial value: $9.79, below the $10 issue price, reflecting dealer discount (1.75 %), hedging and issuance costs.
  • Liquidity & credit: Notes are not exchange-listed; secondary market making is discretionary. All payments depend on UBS AG’s credit; FINMA resolution powers could impose write-downs or conversion to equity.
Key dates include 31 monthly observation dates beginning 7-Aug-2025. Minimum purchase is 100 notes ($1,000). The product suits investors seeking high contingent income, willing to accept equity-like downside, illiquidity, and issuer credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $375,000 of unsubordinated, unsecured Trigger Autocallable Contingent Yield Notes linked to Marvell Technology, Inc. (MRVL) common stock. The notes are issued at $10 each, settle on 10-Jul-2025, and mature on 10-Jan-2028 unless called earlier. Investors receive a contingent monthly coupon of 23.84% p.a. ($0.1987 per note) only when MRVL’s closing price on the relevant observation date is at or above the Coupon Barrier of $52.52 (73 % of the initial level).

  • Automatic call: If MRVL closes at or above the Initial Level of $71.95 on any monthly observation date (other than the final valuation date), UBS redeems the notes at par plus the coupon, ending further payments.
  • Principal at risk: If not called, full principal is repaid only when the Final Level on 6-Jan-2028 is at or above the Downside Threshold of $46.77 (65 % of the initial level). Otherwise, repayment equals $10 × (1 + Underlying Return), exposing investors to the full downside of MRVL below the threshold.
  • Estimated initial value: $9.79, below the $10 issue price, reflecting dealer discount (1.75 %), hedging and issuance costs.
  • Liquidity & credit: Notes are not exchange-listed; secondary market making is discretionary. All payments depend on UBS AG’s credit; FINMA resolution powers could impose write-downs or conversion to equity.
Key dates include 31 monthly observation dates beginning 7-Aug-2025. Minimum purchase is 100 notes ($1,000). The product suits investors seeking high contingent income, willing to accept equity-like downside, illiquidity, and issuer credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

On July 2, 2025, Educational Development Corporation (NASDAQ: EDUC) convened its annual meeting of stockholders. Shareholders elected Dr. Amy N. Emerson as a Class III director for a three-year term, receiving 5,074,815 votes for, 0 against, 89,861 withheld, and 1,360,847 broker non-votes. In a second proposal, investors ratified HoganTaylor LLP as the Company’s independent registered public accounting firm for the fiscal year ending February 28, 2026, with 6,257,164 votes for, 18,822 against, 249,537 abstain/withheld, and 0 broker non-votes. No additional matters were submitted for shareholder action.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

On July 2, 2025, Educational Development Corporation (NASDAQ: EDUC) convened its annual meeting of stockholders. Shareholders elected Dr. Amy N. Emerson as a Class III director for a three-year term, receiving 5,074,815 votes for, 0 against, 89,861 withheld, and 1,360,847 broker non-votes. In a second proposal, investors ratified HoganTaylor LLP as the Company’s independent registered public accounting firm for the fiscal year ending February 28, 2026, with 6,257,164 votes for, 18,822 against, 249,537 abstain/withheld, and 0 broker non-votes. No additional matters were submitted for shareholder action.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

On July 2, 2025, Educational Development Corporation (NASDAQ: EDUC) convened its annual meeting of stockholders. Shareholders elected Dr. Amy N. Emerson as a Class III director for a three-year term, receiving 5,074,815 votes for, 0 against, 89,861 withheld, and 1,360,847 broker non-votes. In a second proposal, investors ratified HoganTaylor LLP as the Company’s independent registered public accounting firm for the fiscal year ending February 28, 2026, with 6,257,164 votes for, 18,822 against, 249,537 abstain/withheld, and 0 broker non-votes. No additional matters were submitted for shareholder action.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

On July 2, 2025, Educational Development Corporation (NASDAQ: EDUC) convened its annual meeting of stockholders. Shareholders elected Dr. Amy N. Emerson as a Class III director for a three-year term, receiving 5,074,815 votes for, 0 against, 89,861 withheld, and 1,360,847 broker non-votes. In a second proposal, investors ratified HoganTaylor LLP as the Company’s independent registered public accounting firm for the fiscal year ending February 28, 2026, with 6,257,164 votes for, 18,822 against, 249,537 abstain/withheld, and 0 broker non-votes. No additional matters were submitted for shareholder action.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

On July 2, 2025, Educational Development Corporation (NASDAQ: EDUC) convened its annual meeting of stockholders. Shareholders elected Dr. Amy N. Emerson as a Class III director for a three-year term, receiving 5,074,815 votes for, 0 against, 89,861 withheld, and 1,360,847 broker non-votes. In a second proposal, investors ratified HoganTaylor LLP as the Company’s independent registered public accounting firm for the fiscal year ending February 28, 2026, with 6,257,164 votes for, 18,822 against, 249,537 abstain/withheld, and 0 broker non-votes. No additional matters were submitted for shareholder action.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

What is the current stock price of ETRACS Whitney US Critical Techs ETN (WUCT)?

The current stock price of ETRACS Whitney US Critical Techs ETN (WUCT) is $31.43 as of April 16, 2024.
ETRACS Whitney US Critical Techs ETN

NYSE:WUCT

WUCT Rankings

WUCT Stock Data

2.00M
Securities Brokerage
Finance and Insurance
Switzerland
Zuerich